The invention relates to the technical field of pharmaceutical preparations and discloses a rosuvastatin calcium tablet. [4-[4-fluorophenyl-6-(1-methylethyl)-2-[N_ methyl-(N-methylsulfonyl) amino]-5-pyrimidyl] methyltriphenylphosphonium bromide, (4R-cis)-6-formyl-2, 2-dimethyl-1, 3-dioxane-4-cyclopentyl acetate, potassium carbonate, dimethyl sulfoxide, methylbenzene, acetonitrile, ethyl acetate, methanol, isopropanol, sodium hydroxide, sodium chloride and calcium chloride. According to the rosuvastatin calcium tablet and the preparation process thereof, a plurality of experiments prove that: when reaction temperature is about 75 DEG C in intermediate synthesis, alkali is the optimal experimental condition of the potassium carbonate, and reaction raw materials can react completely, the generation of multiple impurities is prevented, productivity can be improved, and production cost is reduced; a hydrochloric acid solution is added in a rosuvastatin cyclopentyl ester synthesis process toneutralize redundant acid and alkali, so that the generation of the impurities is further reduced; and therefore, high-purity production is achieved.